Zimbabwe has turned down a significant US healthcare agreement worth 367 million US dollars (£272m) over five years over the United States' insistence on confidential information.
This rejection became public following a official document from December was disclosed, revealing that President Emmerson Mnangagwa deemed the deal was "skewed".
A government spokesperson has since stated that the United States was requesting health data for research and commercial purposes but refused to guarantee the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged more dialogue to find a deal acceptable to all parties so the nation's vital HIV treatment initiative can continue.
Wider Background
Zimbabwe's decision comes after a similar situation in Kenya, where a court halted a similar health funding agreement after legal challenges were filed about the security of citizens' health data.
After returning to office recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost transparency and accountability.
Based on reports, 16 nations in Africa have so far signed similar agreements, constituting over $18.3bn of fresh investment.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership would have delivered significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," Tremont said.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to share its genetic material and health information indefinitely, without any equivalent promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"Effectively, our country would provide the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our population should a future pandemic arise."
Sovereignty and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining structures previously established via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage future pandemics.
"This system is intended to guarantee that when a country provides its information, the benefits – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to develop them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to continued dialogue with our US partners on how future co-operation could be arranged in a way that respects the sovereignty and interests of each country."
Health Experts Reaction
A leading public health body said it understood the official position, but suggested that talks need to persist given that much of the nation's Aids initiatives were funded by foreign aid.
"In cases where technical issues exist, such as those relating to data governance or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group said.
The situation highlights the complex debate between accepting much-needed foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.